Naveen Pemmaraju: Proud to highlight our world-class Leukemia Fellowship
Naveen Pemmaraju Director of BPDCN Program at the University of Texas MD Anderson Cancer Center, posted on X:
“Proud to highlight our world-class Leukemia Fellowship, featuring wonderful clinical + research opportunities!!! Dedicated program with alums from all over the Led by Dr Garcia Manero and Dr Tapan Kadia also Chair of Department of Leukemia Hagop Kantarjian.
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director. His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023